Request Demo
Last update 08 Aug 2026
Acetaminophen/Naproxen Sodium
Last update 08 Aug 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Naproxen Sodium/Acetaminophen, Tylenol with Naproxen |
Target |
Action inhibitors |
Mechanism COX-1 inhibitors(Cyclooxygenase-1 inhibitors), COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (24 Jul 2026), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC14H14NaO3 |
InChIKeyCNQOEXOJUIMDHW-FVGYRXGTSA-N |
CAS Registry26159-34-2 |
View All Structures (2)
Related
4
Clinical Trials associated with Acetaminophen/Naproxen SodiumNCT05845008
An Open-label, Single-arm, Multiple-dose Study to Evaluate the Safety of a Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents 12 to Less Than 17 Years of Age With Orthodontic Pain
NCT05844995
An Open-label, Single-dose, Pharmacokinetic Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Orthodontic Pain
NCT05868122
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Multidose Clinical Trial to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
100 Clinical Results associated with Acetaminophen/Naproxen Sodium
Login to view more data
100 Translational Medicine associated with Acetaminophen/Naproxen Sodium
Login to view more data
100 Patents (Medical) associated with Acetaminophen/Naproxen Sodium
Login to view more data
100 Deals associated with Acetaminophen/Naproxen Sodium
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Arthritis Pain | United States | 24 Jul 2026 | |
| Back Pain | United States | 24 Jul 2026 | |
| Dysmenorrhea | United States | 24 Jul 2026 | |
| Myalgia | United States | 24 Jul 2026 | |
| Toothache | United States | 24 Jul 2026 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pain | Phase 3 | United States | 15 Jan 2024 | |
| Pain, Postoperative | Phase 3 | United States | 22 May 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free